cancer clinical trials in boston, MA
Massachusetts General Hospital
Trial Locations Massachusetts General Hospital Beth Israel Deaconess Medical Center` Renal Cell Carcinoma, Neoplasm Metastases
|
Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute
Boston, Massachusetts 02115 Brain and Central Nervous System Tumors, Neurofibromatosis Type 1, Neurofibromatosis Type 2, Precancerous Condition
|
Dana Farber Cancer Institute
Boston, Massachusetts 02115 Brain and Central Nervous System Tumors, Recurrent Glioblastoma Multiforme
|
Boston University Cancer Research Center
Boston, Massachusetts 02118 Cognitive/Functional Effects, Metastatic Cancer, Neurotoxicity, Unspecified Adult Solid Tumor, Protocol Specific
|
Beth Israel Deaconess Medical Center
Trial Locations Beth Israel Deaconess Medical Center Dana-Farber Cancer Institute Massachusetts General Hosptial Non-small Cell Lung Cancer
|
Massachusetts General Hospital
Boston, Massachusetts 02114-2617 Neuroblastoma
|
Beth Israel Deaconess Medical Center
Trial Locations Beth Israel Deaconess Medical Center Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute Massachusetts General Hospital Dana-Farber/Brigham and Women's Cancer Center Boston University Cancer Research Center Prostate Cancer
|
Dana-Farber Cancer Institute
Trial Locations Dana-Farber Cancer Institute Boston Medical Center Brigham and Women's Hospital Neuroendocrine Carcinoma
|
Dana-Farber Cancer Institute
Boston, Massachusetts 02115 Waldenstrom's Macroglobulinemia
|
Dana-Farber Cancer Institute
Boston, Massachusetts 02115 Adult Nasal Type Extranodal NK/T-cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Nodal Marginal Zone B-cell Lymphoma, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Adult Non-Hodgkin Lymphoma, Recurrent Adult T-cell Leukemia/Lymphoma, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Recurrent Small Lymphocytic Lymphoma, Splenic Marginal Zone Lymphoma, Stage III Adult Burkitt Lymphoma, Stage III Adult Diffuse Large Cell Lymphoma, Stage III Adult Diffuse Mixed Cell Lymphoma, Stage III Adult Diffuse Small Cleaved Cell Lymphoma, Stage III Adult Hodgkin Lymphoma, Stage III Adult Immunoblastic Large Cell Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage III Adult Non-Hodgkin Lymphoma, Stage III Adult T-cell Leukemia/Lymphoma, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Grade 1 Follicular Lymphoma, Stage III Grade 2 Follicular Lymphoma, Stage III Grade 3 Follicular Lymphoma, Stage III Mantle Cell Lymphoma, Stage III Marginal Zone Lymphoma, Stage III Mycosis Fungoides/Sezary Syndrome, Stage III Small Lymphocytic Lymphoma, Stage IV Adult Burkitt Lymphoma, Stage IV Adult Diffuse Large Cell Lymphoma, Stage IV Adult Diffuse Mixed Cell Lymphoma, Stage IV Adult Diffuse Small Cleaved Cell Lymphoma, Stage IV Adult Hodgkin Lymphoma, Stage IV Adult Immunoblastic Large Cell Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Stage IV Adult Non-Hodgkin Lymphoma, Stage IV Adult T-cell Leukemia/Lymphoma, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Grade 1 Follicular Lymphoma, Stage IV Grade 2 Follicular Lymphoma, Stage IV Grade 3 Follicular Lymphoma, Stage IV Mantle Cell Lymphoma, Stage IV Marginal Zone Lymphoma, Stage IV Mycosis Fungoides/Sezary Syndrome, Stage IV Small Lymphocytic Lymphoma, Unspecified Adult Solid Tumor, Protocol Specific, Waldenström Macroglobulinemia
|
Beth Israel Deaconess Medical Center
Trial Locations Beth Israel Deaconess Medical Center Dana-Farber Cancer Institute Massachusetts General Hospital Pancreatic Neuroendocrine Tumor
|
Dana-Farber Cancer Institute
Trial Locations Dana-Farber Cancer Institute Massachusetts General Hospital Mucosal Melanoma, Acral/Lentiginous Melanoma
|
Massachusetts General Hospital
Boston, Massachusetts 02114-2617 Breast Cancer
|
Massachusetts General Hospital
Boston, Massachusetts 02114-2617 Lung Cancer
|
Beth Israel Deaconess Medical Center
Boston, Massachusetts 02215 Pancreatic Cancer
|
Beth Israel Deaconess Medical Center
Trial Locations Beth Israel Deaconess Medical Center Dana-Farber Cancer Institute Massachusetts General Hosptial Breast Cancer
|
DFCI
Boston, Massachusetts 02215 Cancer
|
Boston Medical Center
Boston, Massachusetts 02118 Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary
|
Massachusetts General Hospital
Boston, Massachusetts 02114-2617 Lymphedema, Musculoskeletal Complications, Radiation Fibrosis, Radiation Toxicity, Sarcoma
|
Dana Farber Cancer Institute
Boston, Massachusetts 02115 CNS Cancer, Meningioma, Intracranial Hemangiopericytoma, Hemangioblastoma, Neurofibromatosis
|
Dana-Farber Cancer Institute
Trial Locations Dana-Farber Cancer Institute Massachusetts General Hospital Non-rhabdomyosarcoma Soft Tissue Sarcoma, Bone Sarcoma
|
Massachusetts General Hospital
Boston, Massachusetts 02114-2617 Nasopharyngeal Carcinoma
|
Dana-Farber Cancer Institute
Trial Locations Dana-Farber Cancer Institute Massachusetts General Hospital Rhabdomyosarcoma
|
Beth Israel Deaconess Medical Center
Trial Locations Beth Israel Deaconess Medical Center Dana-Farber Cancer Institute Brigham and Women's Hospital Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IV Breast Cancer
|
Dana-Farber Cancer Institute
Boston, Massachusetts 02115 B-cell Chronic Lymphocytic Leukemia, Leukemia, Prolymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia, Stage IV Chronic Lymphocytic Leukemia
|
Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute
Trial Locations Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Massachusetts General Hospital Dana-Farber/Brigham and Women's Cancer Center Boston University Cancer Research Center Colorectal Cancer
|
Beth Israel Deaconess Medical Center
Boston, Massachusetts 02215 Breast Cancer
|
BIDMC
Boston, Massachusetts 02215 Metastatic Melanoma
|
Children's Hospital Boston
Boston, Massachusetts 02115 Neutropenia, Infection
|
Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute
Boston, Massachusetts 02115 Chronic Lymphocytic Leukemia, CLL, Untreated, Front-line, First-Line, Initial Therapy
|
Beth Israel Deaconess Medical Center
Trial Locations Beth Israel Deaconess Medical Center Dana-Farber Cancer Institute Hepatic Veno-Occlusive Disease
|